LGC Acquires SeraCare Life Sciences, Expands Into Clinical Quality Control Market

(GenomeWeb) – LGC announced today that it has acquired SeraCare Life Sciences, a provider of quality control materials for the infectious disease testing and next-generation sequencing markets. 

According to LGC, the acquisition strengthens the firm's position across the clinical quality control tools market and expands its calibration verification materials and proficiency testing offerings.

Click to see full article